NEJM Journal Watch
@jwatch
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.
ID: 25952049
http://www.jwatch.org 23-03-2009 04:22:46
13,13K Tweet
60,60K Takipçi
123 Takip Edilen
Does pneumococcal vaccination protect people using long-term immunosuppressive agents? jwat.ch/3yVX81H Abigail Zuger MD #vaccine #MedTwitter
A new trial closes the door on chelation therapy for reducing cardiovascular risk in patients with coronary artery disease and prior myocardial infarction, writes Dr. Karol Watson. jwat.ch/3Z42HFV #cardiology
Seeking the Optimal Antithrombotic Therapy After Left Atrial Appendage Occlusion In a small trial, risk for bleeding or thrombotic events was lower with low-intensity direct oral anticoagulants than with dual antiplatelet therapy. jwat.ch/3X6wbk0 Behnood Bikdeli #cardiology
Will GLP-1–receptor agonists break the (Medicare) bank? A recent study estimated that 3.6 million Medicare patients with elevated BMI and established cardiovascular disease would be newly eligible for GLP-1 agonist therapy. jwat.ch/473VJTt Daniel Dressler #glp1
How do long-term outcomes differ between lobular carcinoma and breast cancer of no special type? jwat.ch/3XxcDH2 #bcsm William Gradishar, MD